RT Journal Article
SR Electronic
T1 Implementation of a qPCR assay coupled with genomic surveillance for real-time monitoring of SARS-CoV-2 variants of concern
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.20.21256969
DO 10.1101/2021.05.20.21256969
A1 Rego, Natalia
A1 Costábile, Alicia
A1 Paz, Mercedes
A1 Salazar, Cecilia
A1 Perbolianachis, Paula
A1 Spangenberg, Lucía
A1 Ferrés, Ignacio
A1 Arce, Rodrigo
A1 Fajardo, Alvaro
A1 Arleo, Mailen
A1 Possi, Tania
A1 Bellini, Inés
A1 Bilbao, Lucia
A1 Reyes, Natalia
A1 Bentancor, Ma Noel
A1 Lizasoain, Andrés
A1 Benítez, María José
A1 Castells, Matías
A1 Victoria, Matías
A1 Maya, Leticia
A1 Bortagaray, Viviana
A1 Moller, Ana
A1 Bello, Gonzalo
A1 Arantes, Ighor
A1 Brandes, Mariana
A1 Smircich, Pablo
A1 Chappos, Odhille
A1 Duquía, Melissa
A1 González, Belén
A1 Griffero, Luciana
A1 Méndez, Mauricio
A1 Techera, Ma Pía
A1 Zanetti, Juan
A1 Rivera, Bernardina
A1 Maidana, Matías
A1 Alonso, Martina
A1 Alonso, Cecilia
A1 Medina, Julio
A1 Albornoz, Henry
A1 Colina, Rodney
A1 Noya, Veronica
A1 Iraola, Gregorio
A1 Fernández-Calero, Tamara
A1 Moratorio, Gonzalo
A1 Moreno, Pilar
YR 2021
UL http://medrxiv.org/content/early/2021/05/22/2021.05.20.21256969.abstract
AB We developed a genomic surveillance program for real-time monitoring of SARS-CoV-2 variants of concern in Uruguay. Here, we present the first results, including the proposed qPCR-VOC method, the general workflow and the report of the introduction and community transmission of the VOC P.1 in Uruguay in multiple independent events.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by FOCEM-Fondo para la Convergencia Estructural del Mercosur (COF03/11). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Ministry of Health (Uruguay) is the main health Institution in our country. It is a dedicated ethics oversight body and has granted us the ethical approval for this work. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData was uploaded to GISAID